Predictability of Immunologic Phenotype by Morphologic Criteria in Diffuse Aggressive non-Hodgkin’s Lymphomas
- 1 January 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 77 (1) , 46-49
- https://doi.org/10.1093/ajcp/77.1.46
Abstract
Diffuse aggressive non-Hodgkin’s lymphomas are immunologically and morphologically heterogeneous. Morphologic subclassifications have been proposed with a presumptive relationship to immunologic phenotype. Six histologic types were studied, four of presumed follicular origin (large cleaved, large non-cleaved, mixed follicular center cell, and blastic) and two of presumed nonfollicular origin (pleomorphic pyroninophilic and pleomorphic convoluted). Two of these follicular subtypes were found to be associated with the frequent presence of B-cell markers; large non-cleaved, six of seven; and blastic, four of six. However, four of nine T-cell lymphomas were misclassified as lesions of follicular center cell type, indicating the difficulty of distinguishing some convoluted cells of T-cell lymphoma from irregularly cleaved cells of follicular lymphoma. Pleomorphic pyroninophilic or B-immunoblastic morphology was associated with B-cell markers in only two of six cases; two additional cases had T-cell markers, one had histiocytic markers and in one case, no markers were demonstrable. Thus, this morphology may reflect a common pathway of transformed lymphoid cells. Some cases of T-cell origin could be recognized by the striking pleomorphic convoluted histology (three of five cases) but morphologic overlap with pleomorphic B-cell tumors, particularly transformed nodular lymphomas, posed a problem. This histopathologic subclassification correctly predicted immunologic phenotype in only 61% of cases, suggesting that in diffuse non-Hodgkin’s lymphomas, histologic appearance alone may not be a reliable indicator of immunologic surface markers.Keywords
This publication has 8 references indexed in Scilit:
- Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markersCancer, 1980
- Malignant Lymphoma, T-cell Type: A Distinct Morphologic Variant with Large Multilobated Nuclei, with a Report of Four CasesAmerican Journal of Clinical Pathology, 1979
- Clinical Utility of Lymphocyte Surface Markers Combined with the Lukes-Collins Histologic Classification in Adult LymphomaNew England Journal of Medicine, 1979
- Predictability of immunologic phenotype of malignant lymphomas by conventional morphology. A study of 60 casesCancer, 1979
- Clinical Relevance of the Histopathological Subclassification of Diffuse “Histiocytic” LymphomaNew England Journal of Medicine, 1978
- Non-hodgkin's lymphomas.A clinicopathologic study comparing two classificationsCancer, 1978
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976